The effect of rosiglitazone is modulated by the genetic background in models of dyslipidemia and insulin resistance

Abstract

pharmacogenetics, thiazolidinediones, congenic strains, Cd36/Fat

Keywords

• effect
• rosiglitazone
• modulated
• genetic
• background
• models
• dyslipidemia
• insulin
• resistance